These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Intracranial Schistosoma mekongi infection. Carmody D; Nolan C; Allcutt D Ir Med J; 2008; 101(10):315. PubMed ID: 19205144 [No Abstract] [Full Text] [Related]
31. A case of imported neurocysticercosis in Portugal. Valadas E; Badura R; Marques T; Neno M; Boura M; Sutre AF; Beato S; Grácio MA; Neves JC J Infect Dev Ctries; 2015 Jan; 9(1):114-7. PubMed ID: 25596581 [TBL] [Abstract][Full Text] [Related]
32. [Late results in the treatment of cerebral cysticercosis using praziquantel]. Robles C Salud Publica Mex; 1982; 24(6):625-7. PubMed ID: 6764307 [No Abstract] [Full Text] [Related]
33. Relationship between cysticercosis and epilepsy. Monteiro L; Lopes J; Martins da Silva A Epilepsia; 1999 Oct; 40(10):1464-5. PubMed ID: 10528946 [No Abstract] [Full Text] [Related]
34. Neurocysticercosis: changes after 25 years of medical therapy. Sotelo J; Diaz-Olavarrieta C Arch Med Res; 2010 Jan; 41(1):62-3. PubMed ID: 20430257 [No Abstract] [Full Text] [Related]
35. [Pharmacoeconomic analysis of the short scheme praziquantel in the treatment of neurocysticercosis]. Medina-Santillán R; Mateos-García E; Reyes-García G; Castañeda-Hernández G; Sotelo J Gac Med Mex; 2002; 138(2):203-7. PubMed ID: 12001432 [TBL] [Abstract][Full Text] [Related]
36. MR observations on the effects of praziquantel in neurocysticercosis. Jena A; Sanchetee PC; Tripathi R; Jain RK; Gupta AK; Sapra ML Magn Reson Imaging; 1992; 10(1):77-80. PubMed ID: 1545685 [TBL] [Abstract][Full Text] [Related]